Business Wire

PAYSAFE

19.10.2021 10:02:14 CEST | Business Wire | Press release

Share
Paysafe extends partnership with ZEN.COM to bridge the gap between cash and digital banking

Leading integrated payments platform, Paysafe (NYSE: PSFE), today announces that it has extended its partnership with payments provider ZEN.COM. Paysafe’s eCash solution, Paysafecash, can now be used by individual customers as well as business clients across 25 countries in Europe to make fast and secure cash deposits into ZEN.COM’s virtual wallets.

After selecting Paysafecash as the top up method in the ZEN.COM mobile app, the customer chooses how much cash to deposit into their account and generates a unique barcode for the transaction. The barcode doesn't have to be used straight away – the customer has 72 hours to proceed further. Within this time, the customer can go to a nearby payment point, scan the barcode at the point of sale terminal and make the payment in cash. The deposited amount will be credited to ZEN.COM’s virtual wallet within minutes. The wallet can manage accounts in 30 currencies and can be used for currency exchange and as a payment card. What’s more, thanks to an integrated IBAN number, the wallet complements the traditional bank account and enables money transfers.

ZEN.COM’s integration of Paysafecash provides a highly sought-after cash loading option for digital banking customers in the following 25 countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and the UK.

Today’s announcement is the latest development in an ongoing collaboration between the two companies. ZEN.COM’s business clients already have the option of accepting payments via Paysafe’s leading prepaid solution paysafecard and digital wallet Skrill. Furthermore, paysafecard has been enabled for wallet loading and there are also plans for further integrations of Paysafe’s payments solutions.

Michał Bogusławski, Commercial Director of ZEN.COM commented, “The financial services industry and the consumer needs within it are changing on a daily basis. However, the general trends give us a clear indication that consumers are looking for simplicity in addition to security. In order to fulfil these needs, innovation and cooperation between industry players is key. At ZEN.COM, we strive to cater to both businesses and customers by providing them with an all-in-one solution. Our cooperation with Paysafe, our valued partner over many years, benefits multiple audiences by allowing us to provide merchants with a wider variety of payment methods and enable customers to use their preferred payment method. As an agile and trustworthy partner, Paysafe is a pleasure to work with.”

Udo Müller, CEO of Paysafe’s eCash division, which encompasses paysafecard and Paysafecash , added: “I’m excited about extending our partnership with ZEN.COM to provide a cash-based deposit functionality with Paysafecash. Our eCash network is extremely well established and continually expanding, making this a very convenient and accessible wallet-loading option for ZEN.COM’s cash-based customers, especially as cash remains a cornerstone of the payment landscape in many of these countries.”

~ENDS~

About Paysafecash
Paysafecash, from leading specialised payments platform Paysafe, is an eCash payment method for customers who want to pay online easily and safely using cash. Available in nearly 30 countries, Paysafecash makes online transactions possible for customers, who do not have a debit or credit card, or who do not want to use them online. Payments are made by generating a barcode during the online checkout, which can then be scanned and paid for in person at one of more than 190,000 payment points. Paysafecash was launched in 2018 by the same Paysafe team who created the award-winning, prepaid cash solution paysafecard in 2000. A market leader in eCash payment solutions, paysafecard allows customers to buy prepaid vouchers that they can then redeem online.

About Paysafe Limited
Paysafe Limited (“Paysafe”) (NYSE: PSFE) (PSFE.WS) is a leading specialized payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through industry-leading capabilities in payment processing, digital wallet, and online cash solutions. With over 20 years of online payment experience, an annualized transactional volume of US $100 billion in 2020, and approximately 3,400 employees located in 12+ global locations, Paysafe connects businesses and consumers across 70 payment types in over 40 currencies around the world. Delivered through an integrated platform, Paysafe solutions are geared toward mobile-initiated transactions, real-time analytics and the convergence between brick-and-mortar and online payments. Further information is available at www.paysafe.com .

About ZEN.COM
ZEN.COM is an innovative payment model that debuted in November 2020 in response to the challenges posed by the growing e-commerce market. By changing the approach to online trade and paying for purchases, it aims to support both merchants and consumers. As a financial institution, ZEN.COM holds an e-money license under the supervision of the Central Bank of Lithuania, and the European Banking Authority has approved the company's operations throughout the European Economic Area (EEA). As a result, fintech’s services are available across 31 European countries. ZEN.COM has also earned the trust of leading payment institutions. The fintech is a direct partner of many payment organizations, such as Mastercard, VISA, American Express, Union Pay, and in cooperation with global and local payment methods strives to meet the most demanding expectations of users. The company was founded by Dawid Rożek, creator of the international success of the auction site for players with 20 million customers.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye